Kaken Pharmaceutical Co., Ltd. (4521.T) - Stock Prices, Stock Peers & Analysis

Home
4521.T

Company Name	Kaken Pharmaceutical Co., Ltd.
Symbol	4521.T
Currency	JPY
Price	3,915
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	148,259,668,005
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	4.44%
52-week-range	3,161 - 4,217
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Hiroyuki Horiuchi
Website	https://www.kaken.co.jp

An error occurred while fetching data.

About Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue;